When follow-up was restricted to the period before initiation of the IMPACT screening trial [27], in addition to the entire follow-up for participants from non–IMPACT-recruiting centres, there was no association with PCa risk for BRCA1 carriers (SIR 0.74, 95% CI 0.18–3.04). Here, BRCA1 is linked to posterior cortical atrophy.